ArticleObesity (Silver Spring, Md.)2025
Family Considerations in the Treatment of Adult Obesity With Antiobesity Medications.
Article in Obesity (Silver Spring, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient Knowledge of GLP-1 Receptor Agonists for Obesity and Exploration of Potential Household-Level Effects in an Urban Health System.Obesity science & practice · 2026Article
- Evaluating the Impact on Adult Caregivers of Family-Based Treatment for Childhood Obesity.Obesity science & practice · 2026Article
- Family Considerations in the Treatment of Adult Obesity With Antiobesity Medications.Obesity (Silver Spring, Md.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Adult weight management guidelines recommend offering antiobesity medications (AOMs) as an adjunct to lifestyle modification approaches. Consequently, prescriptions for AOMs are at an unprecedented high, with some estimates suggesting that one in eight US adults report ever taking an AOM. AOMs induce clinically meaningful weight loss for many; concerns about accessibility, cost, long-term efficacy and safety, and changes in eating behavior and psychosocial functioning remain unanswered. A question that has not been asked pertains to the family system. Family members' acceptability and perception of AOMs may dictate adherence, and established family and household routines and dynamics may influence individual behavior change during or after AOM use. This Perspective considers aspects of the family context with health behavior change and weight loss. The paper concludes with suggestions for future research to explore positive ripple effects and unintended consequences that AOMs could have on individual family members and family dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.